Fig. 3From: Quantitative assessment of PSMA PET response to therapy in castration-sensitive prostate cancer using an automated imaging platform for disease identification and measurementPercent change in PSA and prostate/bed, nodal, and osseous disease PSMA scores for each patientBack to article page